HKND icon

Humankind US Stock ETF
HKND

31.91 USD
-0.39
1.21%
At close Jun 13, 4:00 PM EDT
1 day
-1.21%
5 days
-0.22%
1 month
1.08%
3 months
1.66%
6 months
-2.80%
Year to date
0.44%
1 year
2.67%
5 years
25.98%
10 years
25.98%
0
Funds holding %
of 7,296 funds
–
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 9 [Q4 2024] → 9 (+0) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0% less capital invested

Capital invested by funds: $91.3M [Q4 2024] → $91M (-$316K) [Q1 2025]

0.8% less ownership

Funds ownership: 61.05% [Q4 2024] → 60.25% (-0.8%) [Q1 2025]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for HKND.

See Analyst Rankings

Financial journalist opinion

Positive
Seeking Alpha
1 week ago
HKND: Principles Taking Priority Over Performance
HKND comprises 850+ U.S. companies selected and weighted based on a proprietary "humankind value" score. Its expense ratio is 0.11% and the ETF has $151M in assets. Performance has been poor since its launch on February 23, 2021. HKND has trailed its S&P 1500 Composite Index and its more realistic peers in the large-cap value category. My analysis reveals diversification as a potential source of inconsistent returns, given how Health Care exposure totals 40%. The quality is only average, too.
HKND: Principles Taking Priority Over Performance
See News Rankings
Charts implemented using Lightweight Charts™